NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 201 filers reported holding NEVRO CORP in Q1 2018. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $6,037,000 | -22.9% | 75,600 | -16.3% | 0.03% | -23.5% |
| Q1 2018 | $7,826,000 | +81.0% | 90,300 | +44.2% | 0.03% | +70.0% |
| Q4 2017 | $4,324,000 | +74.0% | 62,633 | +129.1% | 0.02% | +53.8% |
| Q3 2017 | $2,485,000 | +852.1% | 27,339 | +681.1% | 0.01% | +550.0% |
| Q2 2017 | $261,000 | -79.0% | 3,500 | -70.6% | 0.00% | -77.8% |
| Q3 2016 | $1,242,000 | +183.6% | 11,900 | +53.0% | 0.01% | +200.0% |
| Q1 2016 | $438,000 | -62.3% | 7,779 | -54.8% | 0.00% | -25.0% |
| Q4 2015 | $1,161,000 | -6.3% | 17,200 | -35.6% | 0.00% | -42.9% |
| Q3 2015 | $1,239,000 | – | 26,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tiger Eye Capital LLC | 239,122 | $41,392,000 | 8.25% |
| Integral Health Asset Management, LLC | 88,000 | $15,233,000 | 4.53% |
| Iron Triangle Partners LP | 168,761 | $29,213,000 | 3.79% |
| Eos Focused Equity Management, L.P. | 14,002 | $2,424,000 | 2.37% |
| PFM Health Sciences, LP | 311,940 | $53,997,000 | 1.90% |
| Perceptive Advisors | 977,565 | $169,217,000 | 1.82% |
| Rock Springs Capital Management LP | 395,000 | $68,375,000 | 1.45% |
| Lisanti Capital Growth, LLC | 54,302 | $9,400,000 | 1.30% |
| HealthCor Management, L.P. | 156,046 | $27,012,000 | 1.04% |
| FRED ALGER MANAGEMENT, LLC | 2,136,612 | $369,848,000 | 0.96% |